Thinking of joining a study?

Register your interest

Become a volunteer?

NCT07237685 | RECRUITING | Type 2 Diabetes

Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus
Sponsor:

Academic Medical Center - University of Amsterdam (AMC-UvA)

Information provided by (Responsible Party):

M.M. Winter

Brief Summary:

People with type 2 diabetes have a much higher risk of heart disease. One common problem is when the blood vessels that supply the heart become narrowed or blocked by fatty deposits, called plaque. This makes it harder for blood to reach the heart and can lead to serious problems such as chest pain, heart attacks, or even death. This study will follow people with type 2 diabetes who have already had a special heart scan called a coronary CT angiography. This scan takes detailed pictures of the heart's blood vessels. The goal is to understand how heart disease changes over time in people with type 2 diabetes, by looking at repeat scans and other health information. By learning more about how plaque builds up or gets worse, researchers hope to find better ways to identify which patients are most at risk for future heart problems.

Condition or disease

Type 2 Diabetes

Coronary Artery Disease (CAD)

Atherosclerosis Cardiovascular Disease

Study Type : OBSERVATIONAL
Estimated Enrollment : 1000 participants
Official Title : Evaluating Atherosclerotic Disease Progression in High-Risk Patients With Diabetes Mellitus
Actual Study Start Date : 2025-06-06
Estimated Primary Completion Date : 2026-10-01
Estimated Study Completion Date : 2036-10-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Age over 18 years
  • * Previous completion of CCTA scan for CAD assessment
  • * Diagnosed with Type 2 Diabetes and currently receiving glucose lowering treatment
  • * Sufficient image quality of the CCTA scan (at least 2/3 vessels of sufficient quality for assessment).
Exclusion Criteria
  • * Inability to provide written informed consent
  • * Presence of an unstable condition
  • * Ingeligibility for CCTA acquisition due to severe renal dysfunction (eGFR ≤ 30 mL/min/1.73m²) or known hypersensitivity or contraindication to CT contrast agents
  • * Any other treatment or clinically relevant condition that could interfere with the conduct or interpretation of the study in the opinion of the investigator
  • * inability or unwillingness to comply with the protocol requirements, or deemed by investigator to be unfit for the study
  • * Baseline (routine care) CCTA performed \< 2 years or \> 5 years before inclusion
Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus

Location Details

NCT07237685

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

NOT YET RECRUITING

Netherlands,

Amsterdam University Medical Centers

Amsterdam, Netherlands,

RECRUITING

Netherlands,

Cardiology Centers of the Netherlands

Amsterdam, Netherlands,